Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:49 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
CSPPT- Chronic Kidney Diseases Study
NCT01871740 · Shenzhen Ausa Pharmed Co.,Ltd · PHASE4 · withdrawn · last registry update 2016-01-20 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “The sponsor and the PIs both agreed that the CSPPT-CKD should be a sub-study of the CSPPT insted of an independent randomized trial.” | – | Registry record, Shenzhen Ausa Pharmed Co.,Ltd |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against ACE within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2016-11-25Results posted on the registry: Novartis Pharmaceuticals, Enalapril + Aliskiren (NCT00853658)
- 2016-09-14Phase 3 first posted: Novartis Pharmaceuticals, LCZ696 (Sacubitril/Valsartan) + Placebo of LCZ696 (Sacubitril/Valsartan) (NCT02900378)
- 2016-08-15Also stopped (terminated): Novartis Pharmaceuticals, LCZ696 200 mg BID + Enalapril 10 mg BID (NCT01035255)
- 2016-06-28Also stopped (terminated): Meir Medical Center, Lercanidipine/enalapril fixed combination (NCT01211314)
- 2016-04-13Phase 3 first posted: UMC Utrecht, Ceftriaxone + Macrolide + Moxifloxacin or Levofloxacin (NCT02735707)
- 2016-04-06Phase 3 first posted: Sunnybrook Health Sciences Centre, ramipril + perindopril (NCT02729441)
- 2016-04-05Also stopped (terminated): Nanfang Hospital, Southern Medical University, Benazepril + Losartan (NCT00630708)
- 2016-03-07Results posted on the registry: Novartis Pharmaceuticals, Aliskiren + Enalapril (NCT01151410)
- 2016-02-24Also stopped (terminated): Institut National de la Santé Et de la Recherche Médicale, France, perindopril + placebo (NCT01583114)
- 2016-02-09Phase 3 first posted: Novartis Pharmaceuticals, LCZ696 + Enalapril (NCT02678312)
- 2016-01-13Phase 3 first posted: Ethicare GmbH, Enalapril Orodispersible Minitablet (NCT02654678)
- 2016-01-12Phase 3 first posted: Ethicare GmbH, Enalapril Orodispersible Minitablet (NCT02652741)
- 2016-01-12Phase 3 first posted: Ethicare GmbH, Enalapril Orodispersible Minitablet (NCT02652728)
- 2015-12-18Results posted on the registry: The Hospital for Sick Children, Enalaprilat (NCT00741156)
- 2015-11-11Results posted on the registry: Hospital Universitario Pedro Ernesto, Benazepril + Losartan (NCT01603940)
- 2015-11-04Results posted on the registry: Vanderbilt University, Sitagliptin (DPP4 inhibitor) + Substance P, (NCT01413542)
- 2015-10-14Phase 3 first posted: Fuling Central Hospital of Chongqing City, Enalapril Maleate Tablets(as the program-based antihypertension) + Enalapril Maleate and Folic Acid tablets(as the program-based antihypertension) (NCT02575092)
- 2015-10-06Also stopped (withdrawn): The Hospital for Sick Children, Perindopril (NCT01948232)
- 2015-09-07Results posted on the registry: Novartis Pharmaceuticals, LCZ696 200 mg BID + Enalapril 10 mg BID (NCT01035255)
- 2015-08-25Results posted on the registry: Symplmed Pharmaceuticals LLC, XOMA 985 + Amlodipine Besylate (NCT01556997)
- 2015-06-10Phase 3 first posted: Novartis Pharmaceuticals, LCZ696 + Enalapril (NCT02468232)
- 2015-06-09Also stopped (terminated): St George's, University of London, Enalapril 20 mg bd + Candesartan 8 mg bd (NCT00141583)
- 2015-06-03Also stopped (withdrawn): Monash University, Perindopril + Perindopril/amlodipine (NCT01089452)
- 2015-05-04Phase 3 first posted: InCor Heart Institute, Enalapril (NCT02432885)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision